Invesaro

Stocks Health care ARDT

NYSE · Health care

Ardent Health, Inc. (ARDT)

Ardent Health, Inc. brought in $6.5B of revenue over the twelve months to September 30, 2026, up 2.0% from a year earlier. Net income was $146.2M, a net margin of 2.3%. At September 30, 2026 it held $766.2M in cash against $1.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.

Free, no password. An email when ARDT files with the SEC.

Price
$17.93
-0.22% on the day · November 10, 2026
52-week range $7.71 to $18.57
Market cap
$2.5B
Revenue (last 12 months)
$6.5B
+2.0% year on year
Net margin
2.3%
P/E
18.7
on FY2025 diluted EPS

Key facts about Ardent Health, Inc.

Net worth
Ardent Health, Inc. has a market value (market cap) of $2.5B at the latest share price, and shareholders' equity of $1.4B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $6.3B (+6.0% year on year), with net income of $135.8M. Over the 12 months to September 30, 2026: revenue $6.5B, net income $146.2M.
Cash flow
In fiscal 2025 operations brought in $470.5M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Ardent Health, Inc.'s next report is expected around March 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Ardent Health, Inc. does

Ardent Health, Inc. is registered with the SEC under industry code SIC 8062 (Services-General Medical & Surgical Hospitals, NEC). Its shares trade on NYSE under the ticker ARDT.

Revenue and profit by year

Revenue
FY22: $5.1B $5.1B FY22FY24: $5.4B $5.4B FY24FY24: $6B $6B FY24FY25: $6.3B $6.3B FY25
Net income
FY22: $188.9M $188.9M FY22FY24: $53.9M $53.9M FY24FY24: $210.3M $210.3M FY24FY25: $135.8M $135.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$6.3Bn/a$135.8M$0.96n/a
2024$6Bn/a$210.3M$1.58n/a
2024$5.4Bn/a$53.9M$0.43n/a
2022$5.1Bn/a$188.9M$1.50n/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around March 3, 2027.

Estimated from its filing rhythm: 52 weeks after its report of March 4, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where ARDT ranks in Health care

Revenue$6.3B
#54 of 751 in Health care · Top 7%
Revenue growth+6.0%
#340 of 532 in Health care · Bottom 36%
Net margin2.1%
#195 of 544 in Health care · Top 36%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Fiscal yearPer sharePaid outOf profit
2024n/a$00%
2024n/a$00%
2022n/a$174.8M93%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Ardent Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 5, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 3.1% to $1.6B versus the same quarter last year; diluted EPS $0.31 versus -$0.17.
  2. November 4, 2026
  3. October 23, 2026
  4. September 4, 2026
  5. August 10, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 1.4% to $1.6B versus the same quarter last year; diluted EPS $0.12 versus $0.52.
  6. August 4, 2026
  7. June 30, 2026
  8. June 2, 2026
  9. May 26, 2026
  10. May 6, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 7% to $1.6B versus the same quarter last year; diluted EPS $0.28 versus $0.29.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 29, 2026. Insider transactions on SEC

Insider trades

What the people running Ardent Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 25, 2026 Byers David RaynorSVP & Chief Accounting Officer Shares withheld for tax 524 $10.54 $5.5K Form 4
September 25, 2026 Petrovich Stephen C.EVP, GC and Secretary Shares withheld for tax 788 $10.54 $8.3K Form 4
September 25, 2026 Lumsdaine AlfredChief Financial Officer Shares withheld for tax 3,389 $10.54 $35.7K Form 4
July 1, 2026 Caspers DaveCEO and President, Director Received as pay 103,653 - - Form 4
June 5, 2026 Lumsdaine AlfredChief Financial Officer Bought 10,000 $8.81 $88.1K Form 4
June 5, 2026 DeMichiei RobertDirector Bought 11,260 $8.73 $98.3K Form 4
April 1, 2026 Bonick MartinPresident and CEO, Director Shares withheld for tax 10,952 $8.67 $95K Form 4
April 1, 2026 Bonick MartinPresident and CEO, Director Received as pay 134,615 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ARDT

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Chai Trust Company, LLC13G, passive with 2 related filers 54.1% 77,246,499 November 14, 2024
Pure Health Capital Americas 1 SPV RSC LTD (1)13G, passive with 3 related filers 21.2% 30,262,664 November 14, 2024

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

16 insiders reported holding 3,578,856 shares in total, about $64.2M at the last price.

HolderSharesAs of
Bonick MartinPresident and CEO, Director 1,437,937 April 1, 2026
Petrovich Stephen C.EVP, GC and Secretary 773,919 September 25, 2026
Lumsdaine AlfredChief Financial Officer 325,794 September 25, 2026
Caspers DaveCEO and President, Director 174,930 July 1, 2026
Byers David RaynorSVP & Chief Accounting Officer 129,921 September 25, 2026
Goodyear William MDirector 115,367 April 1, 2026
Bynoe Peter C BDirector 115,367 April 1, 2026
Havdala EllenDirector 115,367 April 1, 2026
Webb Robert ThomasDirector 78,215 April 1, 2026
Chernin EthanPresident of Health Services 68,396 March 11, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ARDT

What does Ardent Health, Inc. do?

Ardent Health, Inc. is a company in the Health care sector, listed on NYSE as ARDT. Its shares trade on NYSE under the ticker ARDT.

What is Ardent Health, Inc.'s net worth?

Ardent Health, Inc. has a market value (market cap) of $2.5B at the latest share price, and shareholders' equity of $1.4B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Ardent Health, Inc. profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $146.2M on revenue of $6.5B, a net margin of 2.3%.

How much revenue does Ardent Health, Inc. make?

Over the twelve months to September 30, 2026 Ardent Health, Inc. reported revenue of $6.5B. That is 2.0% more than a year earlier.

When did Ardent Health, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.

When is Ardent Health, Inc.'s next earnings report?

Ardent Health, Inc.'s next report is expected around March 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare ARDT with

Compare ARDT with any company

Follow ARDT

Get an email when Ardent Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when ARDT files with the SEC.

Where the numbers come from

Financial figures are the values Ardent Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.